KVUE (Kenvue Inc.) Short-Term Debt to Capital

Corporate company logo of Kenvue Inc. (KVUE)

Kenvue Inc. (KVUE) management is focusing on marketing formula updates, which is confirmed by the daily price action on the GURU.Markets chart regarding the ratio of short-term liabilities to equity. The indicator value reaches 0.22, reflecting the balance between job stability for researchers and the struggle for brand premiumization against private labels. The business's success relies on pricing power and the control of legal risks.

Ratio of Short-Term Indebtedness to Capital: Kenvue Corp (KVUE) for 02/21/2024 - 10/31/2026
Brand item of Kenvue Inc

Conservative capital demands maximum transparency of the liability structure to assess the issuer's financial stability. This indicator measures the share of short-term borrowings relative to equity, determining the company's dependence on immediate refinancing. For Kenvue Inc. (KVUE), which owns historical blockbuster brands, such a metric confirms the ability to maintain market positions without excessive credit pressure. By analyzing the current level of short-term liabilities to equity, an investor assesses the effectiveness of the business's liquidity management.

Competitors of Kenvue Inc. (KVUE)

Short-Term Debt to Capital HLN|VRNA (Verona Pharma Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital MENS (Jyong Biotech Ltd)|Short-Term Debt to Capital ligand.com LGND|AMRX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital PRGO (Perrigo Company PLC)|Alvotech Corp (ALVO) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Liquidia Inc.|GLPG (Galapagos NV) - Short-Term Debt to Capital|Short-Term Debt to Capital anipharmaceuticals.com|Short-Term Debt to Equity Ratio MNKD (MannKind)|AMPH (Amphastar Pharmaceuticals Inc) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Pacira PCRX|ARS Corp (SPRY) - Current Liabilities to Capital|TBPH: Short-Term Debt to Equity Ratio|aquestive.com - Short-Term Loans to Capital Ratio|SCPH: Short-Term Debt to Capital|Tectonic Therapeutic - Ratio of Short-Term Indebtedness to Capital|TNXP (Tonix Pharmaceuticals Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital SXT China SXTC|Short-Term Debt to Equity Eupraxia Pharmaceuticals (EPRX)|BHST (bioharvest.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity eXoZymes EXOZ|Short-Term Debt to Capital Oramed ORMP|Entera Bio Corp - Short-Term Debt to Capital|Current Liabilities to Capital MindWalk Therapeutics|ABVC BioPharma (ABVC) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio CPIX|Short-Term Debt to Equity Ratio QNTM|Short-Term Debt to Equity FGEN|Short-Term Debt to Equity Ratio TELO (Telomir Pharma)|Short-Term Debt to Capital ranitherapeutics.com (RANI)|Short-Term Debt to Capital SNYR (Synergy CHC)|Rallybio Corp (RLYB) - Current Liabilities to Capital|LEXX: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital PULM (Pulmatrix Inc)|PTHL: Short-Term Debt to Capital|APM - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Lyra Therapeutics, Inc.|Short-Term Debt to Capital Ratio IBO (impactbiomedinc.com)|Short-Term Debt to Capital TNFA|Short-Term Debt to Equity Ratio cbdmd.com YCBD|PainReform Limited - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Coefficient Altamira Therapeutics Ltd (CYTO)|LIPO - Short-Term Debt to Equity|OPTN - Short-Term Debt to Capital|PIRS (Pieris Pharmaceuticals, Inc.) - Short-Term Debt to Equity Ratio|PROC (Procaps Group) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio PTPI|Short-Term Debt to Capital Qilian International Corp|Short-Term Debt to Capital SLRN|TFFP - Current Liabilities to Capital